In addition, LAG3 (lymphocyte activation gene 3, CD223) is another kind of inhibitory receptor (IRs) that has been reported to play a negative regulatory role in cancer immunology by interacting with its ligands (Wang M et al., 2021). The gene discussed is LAG3; the disease is cancer.